Summary:
We are seeking participants for a new clinical research study to evaluate the effectiveness, safety and tolerability of an investigational medication in the treatment of adults with diarrhea-predominant irritable bowel syndrome (IBS-D).
Qualified Participants Must:
• Be 18-65 years of age, inclusive
•
Have diarrhea-predominant irritable bowel syndrome (IBS-D)
•
Have had recurrent abdominal pain on average at least 1 day per week during the previous 3 months
Qualified Participants May Receive:
- Reimbursement for time and travel
- Study-related care and study medicine at no cost (no health insurance required)